Literature DB >> 19884043

CNS-targets in control of energy and glucose homeostasis.

André Kleinridders1, A Christine Könner, Jens C Brüning.   

Abstract

The exceeding efforts in understanding the signals initiated by nutrients and hormones in the central nervous system (CNS) to regulate glucose and energy homeostasis have largely revolutionized our understanding of the neurocircuitry in control of peripheral metabolism. The ability of neurons to sense nutrients and hormones and to adopt a coordinated response to these signals is of crucial importance in controlling food intake, energy expenditure, glucose and lipid metabolism. Anatomical lesion experiments, pharmacological inhibition of signaling pathways, and, more recently, the analysis of conditional mouse mutants with modifications of hormone and nutrient signaling in defined neuronal populations have broadened our understanding of these complex neurocircuits. This review summarizes recent findings regarding the role of the CNS in sensing and transmitting nutritional and hormonal signals to control energy and glucose homeostasis and aims to define them as potential novel drug targets for the treatment of obesity and type 2 diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19884043     DOI: 10.1016/j.coph.2009.10.006

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  21 in total

Review 1.  Central nervous system control of metabolism.

Authors:  Martin G Myers; David P Olson
Journal:  Nature       Date:  2012-11-15       Impact factor: 49.962

Review 2.  Role of Adiposity-Driven Inflammation in Depressive Morbidity.

Authors:  Lucile Capuron; Julie Lasselin; Nathalie Castanon
Journal:  Neuropsychopharmacology       Date:  2016-07-11       Impact factor: 7.853

3.  Pharmacotherapies for Overeating and Obesity.

Authors:  S Yarnell; M Oscar-Berman; Nm Avena; K Blum; Ms Gold
Journal:  J Genet Syndr Gene Ther       Date:  2013-04-01

Review 4.  Modeling obesity and its associated disorders in Drosophila.

Authors:  Irene Trinh; Gabrielle L Boulianne
Journal:  Physiology (Bethesda)       Date:  2013-03

Review 5.  Current and future drug targets in weight management.

Authors:  Renger F Witkamp
Journal:  Pharm Res       Date:  2010-12-23       Impact factor: 4.200

Review 6.  Dysmetabolism and Neurodegeneration: Trick or Treat?

Authors:  Adriana M Capucho; Ana Chegão; Fátima O Martins; Hugo Vicente Miranda; Sílvia V Conde
Journal:  Nutrients       Date:  2022-03-29       Impact factor: 5.717

Review 7.  The brain and brown fat.

Authors:  Cristina Contreras; Francisco Gonzalez; Johan Fernø; Carlos Diéguez; Kamal Rahmouni; Rubén Nogueiras; Miguel López
Journal:  Ann Med       Date:  2014-06-10       Impact factor: 4.709

Review 8.  Role of neuroinflammation in the emotional and cognitive alterations displayed by animal models of obesity.

Authors:  Nathalie Castanon; Giamal Luheshi; Sophie Layé
Journal:  Front Neurosci       Date:  2015-07-03       Impact factor: 4.677

9.  Regulation of glucose tolerance and sympathetic activity by MC4R signaling in the lateral hypothalamus.

Authors:  Donald A Morgan; Latisha N McDaniel; Terry Yin; Michael Khan; Jingwei Jiang; Michael R Acevedo; Susan A Walsh; Laura L Boles Ponto; Andrew W Norris; Michael Lutter; Kamal Rahmouni; Huxing Cui
Journal:  Diabetes       Date:  2015-01-20       Impact factor: 9.461

10.  Brain-derived neurotrophic factor, but not body weight, correlated with a reduction in depression scale scores in men with metabolic syndrome: a prospective weight-reduction study.

Authors:  I-Te Lee; Chia-Po Fu; Wen-Jane Lee; Kae-Woei Liang; Shih-Yi Lin; Chu-Jen Wan; Wayne Huey-Herng Sheu
Journal:  Diabetol Metab Syndr       Date:  2014-02-13       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.